Aldosterone Antagonism and Microvascular Function

NCT01887119 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Failure to recruit sufficient participants

Conditions

Abdominal Obesity Metabolic Syndrome
Insulin Resistance
Hypertension

Interventions

DRUG: Eplerenone
OTHER: Placebo

Sponsor

Maastricht University Medical Center